Rep. Josh Gottheimer Sells Phreesia, Inc. (NYSE:PHR) Shares

Representative Josh Gottheimer (Democratic-New Jersey) recently sold shares of Phreesia, Inc. (NYSE:PHR). In a filing disclosed on April 08th, the Representative disclosed that they had sold between $1,001 and $15,000 in Phreesia stock on March 5th. The trade occurred in the Representative’s “MORGAN STANLEY – SELECT UMA ACCOUNT # 1” account.

Representative Josh Gottheimer also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Fabrinet (NYSE:FN) on 3/24/2026.
• Sold $1,001 – $15,000 in shares of Crown Castle (NYSE:CCI) on 3/24/2026.
• Sold $1,001 – $15,000 in shares of ENN Energy (OTCMKTS:XNGSY) on 3/24/2026.
• Sold $1,001 – $15,000 in shares of Infineon Technologies (OTCMKTS:IFNNY) on 3/12/2026.
• Sold $1,001 – $15,000 in shares of HDFC Bank (NYSE:HDB) on 3/12/2026.
• Sold $1,001 – $15,000 in shares of La-Z-Boy (NYSE:LZB) on 3/12/2026.
• Sold $1,001 – $15,000 in shares of Alcon (NYSE:ALC) on 3/12/2026.
• Sold $1,001 – $15,000 in shares of Intapp (NASDAQ:INTA) on 3/12/2026.
• Purchased $1,001 – $15,000 in shares of SEA (NYSE:SE) on 3/10/2026.
• Purchased $1,001 – $15,000 in shares of ServiceNow (NYSE:NOW) on 3/6/2026.

Phreesia Price Performance

Shares of PHR traded up $0.18 during trading hours on Monday, reaching $8.24. 291,790 shares of the stock traded hands, compared to its average volume of 1,967,339. The company has a current ratio of 1.53, a quick ratio of 1.53 and a debt-to-equity ratio of 0.41. Phreesia, Inc. has a 52-week low of $7.77 and a 52-week high of $32.76. The company’s 50-day moving average price is $11.32 and its two-hundred day moving average price is $16.71. The company has a market cap of $500.72 million, a P/E ratio of 275.00 and a beta of 0.86.

Phreesia (NYSE:PHR) last released its earnings results on Monday, March 30th. The company reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.05). Phreesia had a net margin of 0.48% and a return on equity of 3.23%. The firm had revenue of $127.07 million for the quarter, compared to analysts’ expectations of $126.75 million. During the same quarter last year, the firm posted ($0.11) EPS. The firm’s quarterly revenue was up 15.9% compared to the same quarter last year. On average, analysts anticipate that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts have commented on the stock. Canaccord Genuity Group decreased their price target on shares of Phreesia from $33.00 to $22.00 and set a “buy” rating on the stock in a research note on Tuesday, March 31st. Truist Financial reiterated a “hold” rating and issued a $11.00 price target (down from $24.00) on shares of Phreesia in a research note on Tuesday, March 31st. Stephens decreased their price target on shares of Phreesia from $32.00 to $20.00 and set an “overweight” rating on the stock in a research note on Tuesday, March 31st. Needham & Company LLC decreased their price target on shares of Phreesia from $35.00 to $14.00 and set a “buy” rating on the stock in a research note on Tuesday, March 31st. Finally, Wall Street Zen cut shares of Phreesia from a “buy” rating to a “hold” rating in a research note on Saturday, April 4th. Twelve analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $20.82.

Institutional Trading of Phreesia

Hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. raised its position in shares of Phreesia by 8.3% during the 3rd quarter. Vanguard Group Inc. now owns 5,704,786 shares of the company’s stock valued at $134,177,000 after buying an additional 437,462 shares in the last quarter. New York State Common Retirement Fund raised its position in shares of Phreesia by 727.1% during the 3rd quarter. New York State Common Retirement Fund now owns 136,856 shares of the company’s stock valued at $3,219,000 after buying an additional 120,309 shares in the last quarter. Squarepoint Ops LLC raised its position in shares of Phreesia by 243.6% during the 2nd quarter. Squarepoint Ops LLC now owns 100,922 shares of the company’s stock valued at $2,872,000 after buying an additional 71,553 shares in the last quarter. Greenhouse Funds LLLP raised its position in shares of Phreesia by 16.8% during the 3rd quarter. Greenhouse Funds LLLP now owns 3,882,527 shares of the company’s stock valued at $91,317,000 after buying an additional 557,265 shares in the last quarter. Finally, Bessemer Group Inc. raised its position in shares of Phreesia by 1,065.9% during the 3rd quarter. Bessemer Group Inc. now owns 554,513 shares of the company’s stock valued at $13,043,000 after buying an additional 506,954 shares in the last quarter. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Phreesia

In related news, insider Evan Roberts sold 6,268 shares of the company’s stock in a transaction dated Friday, January 16th. The shares were sold at an average price of $16.36, for a total transaction of $102,544.48. Following the transaction, the insider directly owned 826,554 shares in the company, valued at approximately $13,522,423.44. This represents a 0.75% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Amy Beth Vanduyn sold 2,202 shares of the company’s stock in a transaction dated Friday, January 16th. The shares were sold at an average price of $16.36, for a total transaction of $36,024.72. Following the transaction, the senior vice president owned 157,349 shares in the company, valued at $2,574,229.64. The trade was a 1.38% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 40,367 shares of company stock worth $613,251 in the last three months. 5.50% of the stock is owned by insiders.

About Representative Gottheimer

Josh Gottheimer (Democratic Party) is a member of the U.S. House, representing New Jersey’s 5th Congressional District. He assumed office on January 3, 2017. His current term ends on January 3, 2027.

Gottheimer (Democratic Party) is running for re-election to the U.S. House to represent New Jersey’s 5th Congressional District. He declared candidacy for the 2026 election.

Gottheimer is also running for election for Governor of New Jersey. He declared candidacy for the Democratic primary scheduled on June 10, 2025.

Gottheimer attended the University of Pennsylvania for his undergraduate degree. He became a Thouron Fellow at Oxford and attended Harvard Law School. Gottheimer worked as a speech writer under former President Bill Clinton (D), assisting with two State of the Union addresses, among other projects. Before running for Congress, he worked for Microsoft as a general manager for corporate strategy.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.